US2009143486A1PendingUtilityA1
Charge reversible polymers
Est. expiryJul 6, 2026(expired)· nominal 20-yr term from priority
A61K 31/785A61K 47/59A61K 9/1075A61P 35/00C08G 69/02A61K 47/551A61K 47/593C08G 73/0206A61K 47/30C08G 73/00A61K 47/6907A61K 47/645A61K 9/0019
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described are charge reversible polymers, peptides and their resulting colloidal particles, comprising polymers and peptides having primary and secondary amines that are protected as easily hydrolysable amides. The amides are charge-reversible such that at neutral pH they are negatively charged but become positively charged at pH less than 6 and thus are relatively stable at neutral pH but quickly hydrolyze at pH below 6. Incorporating a drug in a micelle or a polymer comprised of the charge-reversible polymers or peptides provides a drug carrier for delivering the drug preferentially to the solid tumor or other targeted cells.
Claims
exact text as granted — not AI-modified1 . A composition of matter comprising a compound having primary and secondary amines that are protected as easily hydrolysable amides.
2 . A composition of matter as defined in claim 1 , wherein the compound is selected from the group consisting of polymers, peptides, and proteins.
3 . A composition of matter as defined in claim 1 , wherein the amides are stable at neutral pH but hydrolyze at pH below 7.
4 . A composition of matter as defined in claim 1 , wherein the compounds are charge-reversible such that at neutral pH they are negatively charged or neutral but become positively charged at pH less than 7.
5 . A composition of matter as defined in claim 1 , further comprising a colloidal particle formed of the compound.
6 . A composition of matter as defined in claim 1 , further comprising a micelle formed of the compound.
7 . A method of drug delivery to solid tumors and lysosomes, comprising forming of the compound of claim 1 a carrier particle selected from the group consisting of a micelle and a colloidal particle, incorporating a drug in the carrier particle, and injecting the carrier particle into a subject having a solid tumor or lysosome.
8 . A method of drug delivery as defined in claim 7 , wherein the drug is releasably bound to the compound.
9 . A composition, comprising a composition selected from the group consisting of peptides, proteins and other biopolymers that are negatively charged or neutral at pH higher than 7, but become positively charged at pH lower than 7.
10 . A composition as defined in claim 9 , further comprising a bioactive agent and wherein the peptide, protein and other biopolymer hydrolyses at a delivery site of the bioactive agent to release the bioactive agent at the delivery site.
11 . A composition, comprising particles that are negatively charged or neutral at pH higher than 7, but become positively charged at pH lower than 7.
12 . A composition as defined in claim 11 , further comprising a bioactive agent and wherein the bioactive agent is contained inside particles and wherein at least a portion of the particles hydrolyse at a delivery site of the bioactive agent to release the bioactive agent at the delivery site.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.